Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists

Details for Australian Patent Application No. 2007263726 (hide)

Owner Biovitrum AB (publ)

Inventors Savory, Edward Daniel

Agent Shelston IP

Pub. Number AU-A-2007263726

PCT Pub. Number WO2008/000743

Priority 60/837,308 11.08.06 US; 0601396-5 27.06.06 SE

Filing date 26 June 2007

Wipo publication date 3 January 2008

International Classifications

A61K 31/7076 (2006.01)

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (1970.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07H 19/167 (1970.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000743 Priority application(s): WO2008/000743

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263727-2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor

2007263724-Preserving products for harvest fruits and vegetables